Kefu Alc glycosylated heme test system - Taiwan Registration e8e437ec58ffce9a1f6697a76050fefe
Access comprehensive regulatory information for Kefu Alc glycosylated heme test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e8e437ec58ffce9a1f6697a76050fefe and manufactured by INFOPIA CO., LTD.. The authorized representative in Taiwan is BIOFIRST CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
e8e437ec58ffce9a1f6697a76050fefe
DHA00602381009
Product Details
This test system detects hemoglobin Alc (HbAlc%) concentrations in microvascular or venous whole blood as a means of monitoring the medium and long-term mean blood glucose in diabetic patients. Boron affinity analysis is used to separate the glycated hemoglobin from the unglycated site.
B Hematology, pathology, and genetics
B.7470 Analysis of glycosylated hemoglobin
import
Dates and Status
Jul 20, 2012
Jul 20, 2017
Dec 13, 2019
Cancellation Information
Logged out
่จฑๅฏ่ญๅทฒ้พๆๆๆ